tiprankstipranks
Advertisement
Advertisement
PTC Therapeutics Earnings Call Highlights Sephience Momentum
PremiumCompany AnnouncementsPTC Therapeutics Earnings Call Highlights Sephience Momentum
1M ago
PTC Therapeutics price target raised to $92 from $90 at Morgan Stanley
Premium
The Fly
PTC Therapeutics price target raised to $92 from $90 at Morgan Stanley
1M ago
PTC Therapeutics price target raised to $120 from $119 at Barclays
Premium
The Fly
PTC Therapeutics price target raised to $120 from $119 at Barclays
1M ago
PTC Therapeutics: Sephience Uptake, Advancing Pipeline, and Strengthening Financials Support Buy Rating
PremiumRatingsPTC Therapeutics: Sephience Uptake, Advancing Pipeline, and Strengthening Financials Support Buy Rating
1M ago
Balanced Outlook on PTC: Sephience-Driven Growth Offset by Duchenne Headwinds and Unmodeled Vatiquinone Upside Supports Hold Rating
Premium
Ratings
Balanced Outlook on PTC: Sephience-Driven Growth Offset by Duchenne Headwinds and Unmodeled Vatiquinone Upside Supports Hold Rating
1M ago
PTC Therapeutics Tops 2025 Revenue Guidance, Boosts Cash
Premium
Company Announcements
PTC Therapeutics Tops 2025 Revenue Guidance, Boosts Cash
1M ago
PTC Therapeutics Withdraws Translarna NDA After FDA Feedback
PremiumCompany AnnouncementsPTC Therapeutics Withdraws Translarna NDA After FDA Feedback
2M ago
PTC Therapeutics price target raised to $97 from $96 at BofA
Premium
The Fly
PTC Therapeutics price target raised to $97 from $96 at BofA
2M ago
PTC Therapeutics price target raised to $75 from $63 at TD Cowen
Premium
The Fly
PTC Therapeutics price target raised to $75 from $63 at TD Cowen
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100